Literature DB >> 32330300

Dosimetry evaluation of the GammaPod stereotactic radiosurgery device based on established AAPM and IAEA protocols.

Stewart J Becker1, Wesley S Culberson2, Yannick Poirier1, Yildirim Mutaf1, Ying Niu3, Elizabeth M Nichols1, Byongyong Yi1.   

Abstract

PURPOSE: The GammaPod is a novel dedicated prone breast stereotactic radiosurgery (SRS) device recently developed at the University of Maryland Medical Center. This device utilizes multiple rotating Co-60 sources to create highly conformal dose distributions for breast treatments, including boosts, partial breast irradiation, or presurgery SRS. However, due to its small field sizes and nonstandard geometry, existing calibration protocols cannot be directly applied. In this study, we adapt and implement the American Association of Physicists in Medicine Task Group 21 (TG-21) and International Atomic Energy Agency (IAEA) Technical Report Series 483 (TRS 483) protocols for reference dose measurements for the GammaPod. This represents the first published dosimetric investigation GammaPod and is meant to serve as a reference to future users commissioning and calibrating these devices.
METHODS: Reference dose measurements were performed following the TG-21/IAEA TRS 483 protocols using an ADCL-calibrated Exradin A1SL thimble chamber in a polymethyl methacrylate (PMMA) breast-mimicking phantom. Monte Carlo calculations and measurements were also performed in water to determine chamber-specific k PMMA Q m s r , Q 0 f msr , f ref quality conversion factor converting reference field size (fref ) to machine-specific field sizes (fmsr ) (25-mm) as well as k PMMA f clin , f msr , the conversion factor from the (fmsr ) to the clinical field size (fclin ) (15mm). Verification was performed using the thermoluminescent dosimeter remote monitoring service from the Imaging and Radiation Oncology Core (IROC) in Houston, TX.
RESULTS: The (fref ) to (fmsr ) chamber-specific factor k PMMA Q m s r , Q 0 f msr , f ref was 0.992 while the (fmsr ) to (fclin ) chamber-specific k PMMA f clin , f msr factor was 1.014. The radiation absorbed dose to water measured in the PMMA phantom based on the TG-21/IAEA TRS 483 formalism agreed with IROC values to within 1% and 2% for the 25- and 15-mm collimators, respectively.
CONCLUSION: We successfully implemented the TG-21 and TRS 483 reference dosimetry protocols for the GammaPod. These results show agreement between measurements performed with different reference dosimetry protocols and independent thermoluminescent measurements.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  IAEA TRS 483; TG-21; breast; cancer; stereotactic radiosurgery

Mesh:

Year:  2020        PMID: 32330300     DOI: 10.1002/mp.14197

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Workflow guide to delivering a safe breast treatment using a novel stereotactic radiation delivery system.

Authors:  Elizabeth M Nichols; Mariana Guerrero; Sarah McAvoy; Terri Biggins; ByongYong Yi; Stewart J Becker
Journal:  J Radiosurg SBRT       Date:  2021

2.  Reproducibility of a novel, vacuum-assisted immobilization for breast stereotactic radiotherapy.

Authors:  James W Snider; Elizabeth M Nichols; Yildirim D Mutaf; Shifeng Chen; Jason Molitoris; Tejan Diwanji; Stewart J Becker; Steven J Feigenberg
Journal:  J Appl Clin Med Phys       Date:  2021-03-03       Impact factor: 2.102

3.  Correlation of treatment time to target volume for GammaPod treatments: A simple second calculation.

Authors:  Leah Chen; Stewart J Becker; Sarah Anne McAvoy; Elizabeth M Nichols; Mariana Guerrero
Journal:  J Appl Clin Med Phys       Date:  2022-02-07       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.